Common Litigation Risks During Healthcare Transactions

Healthcare transactions—whether mergers, acquisitions, or practice sales—often involve significant legal and regulatory complexity, which can create exposure to litigation if not carefully managed. These risks make it essential for parties to take a proactive approach to identifying and addressing potential issues early in the process. By conducting thorough due diligence, ensuring regulatory compliance, and working closely with experienced legal counsel, organizations can significantly reduce their exposure. Below are some of the top reasons that healthcare transactions head to litigation:

Ambiguous Terms in the Contract

Ambiguous contract terms are a significant source of litigation risk in healthcare transactions. They occur when key provisions are not clearly defined or can reasonably be interpreted in more than one way. This lack of clarity often leads to disputes after closing, particularly in complex areas such as representations and warranties, indemnification obligations, earn-out calculations, and purchase price adjustments.

Breach of Contract

A breach of contract claim may arise when one party alleges that another failed to fulfill a material obligation under the transaction documents. Here are some examples:

Failure to transfer agreed-upon assets
Failure to satisfy closing conditions
Misrepresentation of financial information
Failure to obtain required approvals
Disputes regarding post-closing compensation arrangements
Violations of restrictive covenant provisions

Misrepresentations Made By Either Party

Misrepresentation is another common basis for litigation in healthcare transactions. It usually arises when one party claims the other provided inaccurate or incomplete information during negotiations. Common examples include inflated revenue or patient volume figures. Other examples include failure to disclose regulatory investigations. Misstated reimbursement history or payer mix is also common. Omitted liabilities or pending lawsuits may also give rise to claims. Even if the misstatements are unintentional, they can still create significant legal exposure.

Nondisclosure of Regulatory Compliance Woes

Parties care about full disclosure of healthcare fraud and abuse risks because these issues can materially change a deal’s value, regulatory exposure, and post-closing financial performance. Failure to disclose matters involving laws such as the Stark Law, Anti-Kickback Statute, or HIPAA can therefore create significant legal and operational consequences. Similarly, undisclosed audits, billing investigations, or regulatory sanctions may surface after closing, disrupting integration and reimbursement stability. Common drivers of disputes include ongoing government investigations, prior compliance audits not disclosed during due diligence, improper billing practices or coding errors, and HIPAA privacy or security breaches. When these issues are discovered post-closing, they often lead to indemnification claims, potential regulatory enforcement actions, and, in severe cases, allegations that the seller misrepresented or concealed material compliance problems.

Undisclosed Liabilities

Undisclosed liabilities are a frequent cause of disputes after a transaction closes. They can involve legal claims, tax obligations, contractual conflicts, or regulatory penalties that were not fully revealed during negotiations. Examples include pending malpractice or employment lawsuits, outstanding tax liabilities or reimbursement overpayments, vendor disputes or contract breaches, and contingent liabilities linked to reimbursement audits. When these liabilities surface after closing, buyers may argue that sellers breached representations about full disclosure or the absence of such obligations. This often leads to claims for indemnification, purchase price adjustments, or litigation by the acquiring party to recover losses incurred post-closing.

Insufficient Due Diligence

Due diligence is one of the most important stages of any healthcare transaction, but it is also one of the most common sources of litigation when it is performed improperly or incompletely. Inadequate due diligence can lead to a range of serious problems, including the overvaluation of the target entity, failure to identify regulatory violations, and the discovery of undisclosed liabilities such as pending investigations or audits. It may also lead to incorrect assumptions about reimbursement rates or payer contracts, which can significantly affect the deal’s financial expectations.

Concerns After Closing

Even well-structured transactions can lead to litigation if contractual terms are unclear or disputed after closing. Post-closing disputes often involve the interpretation of representations and warranties, indemnification provisions, earn-out structures, purchase price adjustments, and transition service agreements. For example, disagreements may arise over whether certain liabilities were properly disclosed or whether financial performance metrics were accurately calculated.

Is Litigation Inevitable If There Is Conflict?

Litigation may happen, but it is not necessary. In most transactions, disputes are first addressed through contractual mechanisms such as negotiation, indemnification procedures, expert determination, or escrow and purchase price adjustments. Many deals also include mandatory mediation or arbitration clauses designed to resolve conflicts without going to court. Litigation typically arises only if these processes fail, the contract is unclear, or one party believes the other has materially breached representations or acted in bad faith. Even then, parties often settle before trial.

Strategies to Avoid Risks During Healthcare Transactions

Conduct comprehensive legal and regulatory due diligence: Review all legal, operational, and regulatory aspects of the transaction to identify potential liabilities, compliance gaps, licensing concerns, and obligations before finalizing the deal.
Verify the accuracy of disclosures and representations: Ensure that all statements, warranties, and disclosures provided by each party are complete, accurate, and supported by documentation to reduce the risk of future disputes based on misrepresentation.
Identify pending investigations and claims: Investigate any ongoing audits, government inquiries, litigation, or threatened claims that could affect the transaction’s value or create future exposure.
Clearly document transaction terms: Draft precise agreements outlining rights, obligations, representations, indemnification provisions, and closing conditions to avoid ambiguity.
Establish dispute-resolution procedures: Include mechanisms such as mediation or arbitration to facilitate efficient resolution of conflicts.
Assess insurance coverage needs: Determine whether existing policies are adequate and whether additional coverage is necessary.
Develop detailed post-closing integration plans: Create structured plans that address governance, operations, compliance, staffing, and communication to ensure a smooth transition and reduce post-transaction disputes.

Consult an Experienced Healthcare Law Litigation Attorney

Healthcare transactions often involve complex regulatory requirements, making proactive legal review essential for minimizing exposure. An attorney can assist with due diligence, contract structuring, and compliance strategies tailored to your specific deal. Consult an experienced healthcare law litigation attorney to help identify and manage potential risks before they escalate into costly disputes.